Stocks to Watch Today, Thursday, August 6, 2026: Ola Electric, PB Fintech, Hindalco Industries, Biocon and SIS 

Mumbai, Aug 6: Five stocks are in focus on Thursday, from Ola Electric’s entry into utility-scale battery storage to PB Fintech’s sharp profit jump, Hindalco arm Novelis’ strong quarterly show, Biocon’s fourfold profit surge and SIS’ steady earnings. Here’s what’s driving each stock and what to track through the day. 

Ola Electric (OLAELEC): Signs MoU with Axis Energy to deploy up to 20 GWh of battery storage by 2032 

Ola Electric Mobility on Wednesday said it has signed a Memorandum of Understanding with renewable energy developer Axis Energy to explore the deployment of up to 20 GWh of battery energy storage systems by 2032. The agreement marks the first large-scale commercial partnership for Ola Mahashakti, the company’s forthcoming energy storage platform for commercial, industrial and utility-scale applications, which is scheduled to launch on August 15. Under the pact, the two companies aim to ramp up annual deployments to as much as 5 GWh from 2028. Axis Energy has secured grid approvals for more than 3,750 MW of storage-backed renewable projects across Andhra Pradesh and Rajasthan, with a further pipeline of around 3,500 MW. Ola Electric cited Central Electricity Authority estimates that India will need over 400 GWh of storage capacity by 2032, positioning the deal as validation of its shift beyond electric two-wheelers into grid-scale energy infrastructure. 

PB Fintech (POLICYBZR): Profit jumps 92% to Rs 163 crore in Q1 FY27, margin improves to 9% 

Policybazaar’s parent company reported a consolidated profit after tax of Rs 163 crore in the June quarter of FY27, up 92 per cent year-on-year from Rs 85 crore a year earlier. Its PAT margin improved to 9 per cent from 6 per cent in the corresponding period last year. Revenue from operations climbed 40 per cent year-on-year to Rs 1,888 crore, while total insurance premium rose 41 per cent to Rs 8,372 crore, led by a 53 per cent jump in new protection premium and a 59 per cent increase in health insurance premium. Adjusted EBITDA advanced 109 per cent to Rs 186 crore, with the EBITDA margin expanding 300 basis points to 10 per cent. Employee benefit expenses remained the largest cost head at Rs 716 crore, while advertising spends rose 50 per cent year-on-year to Rs 379 crore. Investors will track customer acquisition trends and the pace of margin expansion in the core insurance business. 

Hindalco Industries (HINDALCO): Arm Novelis posts 71% jump in Q1 net income to $164 million 

Hindalco Industries subsidiary Novelis reported a 71 per cent year-on-year surge in consolidated net income to $164 million for the first quarter of FY27, while net income excluding special items grew 128 per cent to $265 million. Adjusted EBITDA rose 24 per cent to $516 million, helped by lower aluminium scrap prices and cost efficiencies even as higher net tariffs weighed. Rolled product shipments fell 5 per cent to 916 kilo tonnes, hurt by an estimated 33 kilo tonne hit from production disruptions at the Oswego plant, which was restarted in early June following fires in the previous fiscal year. Adjusted EBITDA per tonne shipped zoomed 30 per cent to $563. Commissioning of the greenfield Bay Minette rolling and recycling plant in Alabama is underway, with Novelis guiding to capital expenditure of $2.1 billion to $2.4 billion for FY27. Investors will watch the ramp-up pace at both facilities. 

Biocon (BIOCON): Profit spikes 349.4% to Rs 141.1 crore on biopharma strength 

Biocon reported a 349.4 per cent year-on-year jump in consolidated net profit to Rs 141.1 crore for the June quarter of FY27, compared with Rs 31.4 crore in the same period last year. Revenue from operations rose 10 per cent year-on-year to Rs 4,336 crore against Rs 3,941.9 crore, driven by a 17 per cent surge in the biopharma business, which contributed 83 per cent of total revenue. Within biopharma, biosimilars revenue grew 16 per cent to Rs 2,855 crore and generics revenue rose 21 per cent to Rs 760 crore, while services revenue fell 16 per cent to Rs 736 crore on continued headwinds. Consolidated EBITDA stood at Rs 902 crore, up 7 per cent, with margins steady at 21 per cent. Investors will track the ramp-up of recent biosimilar launches, including Yesafili in the US, and progress on debt reduction. 

SIS (SIS): Profit rises 9.4% to Rs 101.7 crore, revenue up 29.7% in Q1 

Security and facility management services provider SIS reported a 9.4 per cent year-on-year rise in consolidated net profit to Rs 101.7 crore for the June quarter of FY27, compared with Rs 92.9 crore a year earlier. Revenue from operations jumped 29.7 per cent year-on-year to Rs 4,603.6 crore from Rs 3,548.5 crore, reflecting continued momentum across its security solutions, facility management and cash logistics businesses in India and international markets. The results come days after the company’s board approved an in-principle proposal for a share buyback of up to Rs 120 crore, and after SIS raised its stake in Updater Services to 6.65 per cent. Management, which has termed FY27 an inflection year, will host an earnings call later on Thursday, where investors will look for commentary on margin trends and progress on deleveraging. 

Source

• Company filings, BSE, NSE, PTI and business media reports